SCHEDULE 13G/A: Bigger Capital and Affiliates Update Passive Stake in Intelligent Bio Solutions, Capped by Warrant Limitations

Bigger Capital Fund L.P., District 2 Capital Fund L.P., and related entities, including Michael Bigger, have filed an amended Schedule 13G, disclosing their passive beneficial ownership in Intelligent Bio Solutions Inc., with holdings capped by a 4.99% beneficial ownership limitation on exercisable warrants.

Summary

• Bigger Capital Fund L.P. and its general partner, Bigger Capital Fund GP, LLC, beneficially own 227,274 shares of Intelligent Bio Solutions Inc. Common Stock, representing approximately 4.93% of the outstanding shares.
• District 2 Capital Fund L.P., along with its investment manager District 2 Capital L.P., general partner District 2 GP LLC, and managing member District 2 Holdings LLC, beneficially own 75,758 shares, representing approximately 1.7% of the outstanding shares.
• Michael Bigger, as the managing member of Bigger Capital Fund GP, LLC and District 2 Holdings LLC, is deemed to beneficially own a combined total of 303,032 shares (227,274 + 75,758), representing approximately 4.99% of the outstanding shares.
• All reported beneficial ownership is derived from shares issuable upon the exercise of Warrants.
• A key term of the Warrants includes a 'Blocker' provision, which prevents the Reporting Persons or their affiliates from exercising Warrants if it would result in beneficial ownership exceeding 4.99% of the outstanding shares.
• The percentages are calculated based on 4,386,816 shares of Common Stock outstanding as of November 4, 2024, as reported in the Company's Form 10-Q for the six months ended September 30, 2024, and include the exercisable Warrants in the denominator.
• The filing confirms that the securities were not acquired and are not held for the purpose of changing or influencing the control of the issuer.

Sentiment

Score: 5

Explanation: The document is a factual, regulatory filing (Schedule 13G) reporting beneficial ownership. It contains no positive or negative performance metrics, nor does it indicate any strategic shifts or activist intentions. The sentiment is neutral as it simply updates ownership information.

Positives

• The continued beneficial ownership by these entities indicates a sustained passive investment interest in Intelligent Bio Solutions Inc.

Negatives

• The 'Blocker' provision in the Warrants limits the ability of the Reporting Persons to increase their beneficial ownership beyond 4.99%, potentially restricting their future influence or stake in the company.

Risks

• The 4.99% beneficial ownership limitation (Blockers) on the Warrants means that the Reporting Persons cannot fully exercise all their Warrants if it would push their ownership above this threshold, potentially limiting their upside from the Warrants if the stock price increases significantly and they wish to convert more shares.

Future Outlook

The document does not provide any forward-looking statements or guidance regarding the issuer's financial performance or strategic direction. It solely pertains to the beneficial ownership of the Reporting Persons and their current limitations on warrant exercise.

Industry Context

This Schedule 13G filing is a routine disclosure of passive beneficial ownership and does not provide information that allows for an analysis of broader industry trends or competitive positioning for Intelligent Bio Solutions Inc. It primarily reflects an investment position by specific funds and individuals.

Stakeholder Impact

• Shareholders: Provides transparency regarding significant passive investors and their ownership stakes, including the limitations on their ability to increase their holdings via warrant exercise.

Key Dates

Keywords

Intelligent Bio Solutions Inc., Schedule 13G, Beneficial Ownership, Warrants, Passive Investment, SEC Filing, BIGGER CAPITAL FUND L P, District 2 Capital Fund LP, Michael Bigger, Common Stock